ReWalk Robotics to Report Third Quarter 2019 Financial Results on November 13, 2019
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 08, 2019 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the […]
Highland Copper Announces Filing of NI 43-101 Technical Report for the White Pine North Project in Michigan, USA
LONGUEUIL, Quebec, Nov. 08, 2019 (GLOBE NEWSWIRE) — Highland Copper Company Inc. (TSX-V: HI, OTCQB: HDRSF) (the “Company”) is pleased […]
AgraFlora Organics présente ses premiers produits comestibles devant être fabriqués à son usine de produits comestibles de 51 500 pieds carrés, certifiée GMP, située à Winnipeg et lance une campagne éducative nationale sur les produits comestibles
VANCOUVER, Colombie-Britannique, 08 nov. 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) [...]
RAMM Pharma Corp. Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “RAMM” and Provides Corporate Update
TORONTO, Nov. 08, 2019 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: […]
TRACON Pharmaceuticals Announces Reverse Stock Split
SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development […]
AnaptysBio Announces Third Quarter 2019 Financial Results and Provides Pipeline Updates
Topline Data From Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Failed to Meet Primary EndpointReported Positive Topline […]
InfuSystem to Report Third Quarter 2019 Financial Results on Wednesday, November 13, 2019
MADISON HEIGHTS, MICHIGAN, Nov. 08, 2019 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), a leading national provider of […]
Scholar Rock to Present at the 2019 Jefferies London Healthcare Conference
CAMBRIDGE, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on […]
Sequential Brands Group Announces Third Quarter 2019 Results
NEW YORK, Nov. 08, 2019 (GLOBE NEWSWIRE) — Sequential Brands Group, Inc. (“Sequential” or the “Company”) (Nasdaq:SQBG) today announced financial […]
AnaptysBio Reports Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Fails to Meet Primary Endpoint
SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product […]
